Literature DB >> 8580621

Latent coeliac disease in Italy. The SIGEP Working Group on Latent Coeliac Disease. Italian Society for Paediatric Gastroenterology and Hepatology.

R Troncone1.   

Abstract

The term latent coeliac disease applies to patients who have a normal jejunal biopsy while taking a normal diet and, at some other time, before or since, have had a flat jejunal biopsy recovering on a gluten-free diet. Nineteen such patients were identified after a multicentre search conducted under the auspices of the Italian Society for Paediatric Gastroenterology and Hepatology (SIGEP). Serological data and histological material suitable for morphometric analysis were available from 10 and 8 patients, respectively, while they were on a gluten-containing diet. Neither gliadin antibodies nor increased density of intraepithelial lymphocytes are obligate markers of latent coeliac disease; endomysial antibodies are likely to be best predictors of evolution towards villous atrophy. Prospective studies are needed to allow a more precise definition of latent coeliac patient features.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580621     DOI: 10.1111/j.1651-2227.1995.tb13543.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  11 in total

1.  Latent coeliac disease or coeliac disease beyond villous atrophy?

Authors:  Katri Kaukinen; Pekka Collin; Markku Mäki
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 2.  Is this really celiac disease? Pitfalls in diagnosis.

Authors:  Carlo Catassi; Alessio Fasano
Journal:  Curr Gastroenterol Rep       Date:  2008-10

3.  Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease.

Authors:  M Westerholm-Ormio; J Garioch; I Ketola; E Savilahti
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

4.  Changing jejunal gamma delta T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease.

Authors:  S Iltanen; K Holm; M Ashorn; T Ruuska; P Laippala; M Mäki
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

5.  Celiac disease without villous atrophy: revision of criteria called for.

Authors:  K Kaukinen; M Mäki; J Partanen; H Sievänen; P Collin
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

6.  Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation.

Authors:  Kalle Kurppa; Tiia Räsänen; Pekka Collin; Sari Iltanen; Heini Huhtala; Merja Ashorn; Päivi Saavalainen; Katri Haimila; Jukka Partanen; Markku Mäki; Katri Kaukinen
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

7.  Circulating T lymphocyte subsets in coeliac disease (CoD) patients and healthy family members.

Authors:  T O Kerttula; K Holm; J Partanen; A Polvi; M Mäki
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

8.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

Authors:  I R Korponay-Szabó; T Halttunen; Z Szalai; K Laurila; R Király; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Clinical utility of celiac disease-associated HLA testing.

Authors:  Kumar Pallav; Toufic Kabbani; Sohaib Tariq; Rohini Vanga; Ciaran P Kelly; Daniel A Leffler
Journal:  Dig Dis Sci       Date:  2014-04-06       Impact factor: 3.199

10.  Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa.

Authors:  Jonas F Ludvigsson; Lena Brandt; Scott M Montgomery
Journal:  BMC Gastroenterol       Date:  2009-07-22       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.